| Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue Lu-177-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study | |
| Zhang, Jingjing; Niu, Gang; Wang, Hao; Jacobson, Orit; Cheng, Yuejuan; Zang, Jie; Li, Fang; Bai, Chunmei; Zhu, Zhaohui; Chen, Xiaoyuan | |
| 2018 | |
| 会议名称 | JOURNAL OF NUCLEAR MEDICINE |
| 会议日期 | 2018-05-01 |
| 收录类别 | CPCI-S |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6347289 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhang, Jingjing,Niu, Gang,Wang, Hao,et al. Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue Lu-177-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study[C]. 见:JOURNAL OF NUCLEAR MEDICINE. 2018-05-01. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论